Anthropology in China's health promotion and tobacco.

10 www.thelancet.com 10 Tang JL, Zhan SY, Ernst E. Review of randomised controlled trials of traditional Chinese medicine. BMJ 1999; 319: 160–61. 11 Wang G, Mao B, Xiong ZY, et al. The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China. Clin Ther 2007; 29: 1456–67. 12 Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 1998; 19: 159–66. 13 Tang JL. Research priorities in traditional Chinese medicine. BMJ 2006; 333: 391–94. 14 Tomlinson B, Chan TYK, Chan JCN, Critchley JAHJ, But PPH. Toxicity of complementary therapies: an Eastern perspective. J Clin Pharmacol 2000; 40: 451–56. 15 Medicine and Healthcare Products Regulatory Agency. Tough action by UK medicines regulator against a traditional Chinese medicine containing high levels of mercury. May 16, 2006. http://www.mhra.gov.uk/NewsCentre/ Pressreleases/CON2023749 (accessed July 19, 2008). 16 Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355: 134–38. 17 Brown AC. Potentially life-threatening herbs: reported cases in MEDLINE of liver toxicity, renal toxicity, cardiotoxicity, cancer, and death. 2002. http:// www2.hawaii.edu/~amybrown/PotentiallyHarmfulHerbList%20 -%20Table.pdf (accessed July 9, 2008). 18 European Medicines Agency: Public statement on the risk associated with the use of herbal products containing Aristolochia species. Nov 23, 2005. http://www.emea.europa.eu/pdfs/human/hmpc/13838105en.pdf (accessed July 10, 2008). 19 Vines G. Herbal harvests with a future: towards sustainable sources for medicinal plants. 2004. http://www.plantlife.org.uk/uk/assets/ saving-species/saving-species-publications/Herbal-Harvests-with-aFuture.pdf (accessed July 9, 2008).